Ligand-based approaches to in silico pharmacology.
暂无分享,去创建一个
[1] R. Solé,et al. The topology of drug-target interaction networks: implicit dependence on drug properties and target families. , 2009, Molecular bioSystems.
[2] B Testa,et al. In silico pharmacology for drug discovery: applications to targets and beyond , 2007, British journal of pharmacology.
[3] A. Leo,et al. Chem-bioinformatics: comparative QSAR at the interface between chemistry and biology. , 2002, Chemical reviews.
[4] Brian K. Shoichet,et al. Virtual screening of chemical libraries , 2004, Nature.
[5] Lahana,et al. How many leads from HTS? , 1999, Drug discovery today.
[6] Jürgen Bajorath,et al. Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.
[7] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[8] Roberto Todeschini,et al. Handbook of Molecular Descriptors , 2002 .
[9] S. Ekins,et al. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling , 2007, British journal of pharmacology.
[10] Peter Willett,et al. Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.
[11] P Willett,et al. Similarity-based approaches to virtual screening. , 2003, Biochemical Society transactions.
[12] E. Jacoby,et al. Chemogenomics: an emerging strategy for rapid target and drug discovery , 2004, Nature Reviews Genetics.
[13] Jordi Mestres,et al. SHED: Shannon Entropy Descriptors from Topological Feature Distributions , 2006, J. Chem. Inf. Model..
[14] Hans-Joachim Böhm,et al. A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.
[15] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[16] C. Hansch,et al. p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure , 1964 .
[17] Alka Kurup. C-QSAR: a database of 18,000 QSARs and associated biological and physical data , 2003, J. Comput. Aided Mol. Des..
[18] J. Bajorath. Computational analysis of ligand relationships within target families. , 2008, Current opinion in chemical biology.
[19] Nikolay P Savchuk,et al. Exploring the chemogenomic knowledge space with annotated chemical libraries. , 2004, Current opinion in chemical biology.
[20] Michael J. Keiser,et al. Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.
[21] J. Mestres,et al. A ligand-based approach to mining the chemogenomic space of drugs. , 2008, Combinatorial chemistry & high throughput screening.
[22] M. Karelson. Molecular descriptors in QSAR/QSPR , 2000 .
[23] Thomas Lengauer,et al. Novel technologies for virtual screening. , 2004, Drug discovery today.
[24] Walters Wp,et al. Feature selection in quantitative structure-activity relationships. , 2005 .